According to researchers, characteristics of glioblastoma including seizures, location, and pressure in the brain give valuable insight into length of survival as well as treatment options for patients over the age of 70 years.
Oncologists need to be more aware of drug-drug interactions with newer oral antineoplastic agents, according to a study published in JAMA Oncology.
The neutrophil-to-lymphocyte ratio may not be as reliable as previously believed at predicating cancer progression and which drugs will be the most effective.
Tumor cells collected during the removal of a cancerous bladder may help clinicians better identify high-risk cancers, determine prognosis, refine their use of biomarkers, and provide more personalized care, according to a study published in Scientific Reports.
Esophageal cancer may be 3 distinct diseases, which could pave the way for new methods of diagnosis and the development of targeted treatment regimens.
Vemurafenib, a drug originally approved for use in patients with BRAF-positive melanoma, has also shown promising anti-tumor activity in some patients harboring this same mutation in thyroid cancer, according to the results of a study published in Lancet Oncology.